The scientist’s investigation covers issues in Immunology, Cell biology, Extracellular, Molecular biology and Adenosine. His Immunology research integrates issues from Xenotransplantation and Transplantation. His studies examine the connections between Cell biology and genetics, as well as such issues in Purinergic signalling, with regards to Adenosine A3 receptor.
Simon C. Robson usually deals with Extracellular and limits it to topics linked to Ectonucleotidase and Microglia and Cell. His study looks at the relationship between Molecular biology and fields such as Endothelial stem cell, as well as how they intersect with chemical problems. His Adenosine research is multidisciplinary, incorporating elements of ATP hydrolysis, Adenosine A2B receptor, Adenosine receptor, Pharmacology and Effector.
Simon C. Robson spends much of his time researching Immunology, Internal medicine, Cell biology, Adenosine and Transplantation. The various areas that he examines in his Immunology study include Xenotransplantation and Pharmacology. The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Cardiology.
His Cell biology study combines topics in areas such as Endothelial stem cell, Biochemistry and Purinergic signalling. His biological study spans a wide range of topics, including Receptor, Cancer research and Adenosine receptor. His Transplantation study integrates concerns from other disciplines, such as Immunosuppression and Pathology.
His primary areas of study are Immunology, Internal medicine, Cancer research, Inflammation and Purinergic signalling. His study in Transplantation extends to Immunology with its themes. The study incorporates disciplines such as Gastroenterology, Endocrinology and Oncology in addition to Internal medicine.
His studies deal with areas such as Extracellular, Purinergic receptor and Cell biology as well as Purinergic signalling. His study in Extracellular is interdisciplinary in nature, drawing from both Adenosine and Adenosine receptor. Simon C. Robson has included themes like Platelet and T cell in his Cell biology study.
His primary scientific interests are in Inflammation, Immune system, Immunology, Purinergic signalling and Internal medicine. His research in Inflammation intersects with topics in Ectonucleotidase and Adenosine. The study incorporates disciplines such as Extracellular, Adenosinergic, Adenosine receptor and Transplantation in addition to Adenosine.
His research integrates issues of Cancer research and Inflammatory bowel disease in his study of Immune system. His biological study spans a wide range of topics, including Protein kinase A, Pharmacology and Gene knockdown. His Purinergic signalling research is multidisciplinary, incorporating perspectives in Fibrosis, Purinergic receptor, Purinergic Agents and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio;Karen M. Dwyer;Wenda Gao;David J Friedman.
Journal of Experimental Medicine (2007)
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
Simon Christopher Robson;Jean Sévigny;Herbert Zimmermann.
Purinergic Signalling (2006)
Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience.
Kenji Kuwaki;Yau Lin Tseng;Frank J.M.F. Dor;Akira Shimizu.
Nature Medicine (2005)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.
Bertrand Allard;Maria Serena Longhi;Simon C. Robson;John Stagg.
Immunological Reviews (2017)
Purinergic Signaling during Inflammation
Holger K. Eltzschig;Michail V. Sitkovsky;Simon C. Robson.
The New England Journal of Medicine (2012)
Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase
Elzbieta Kaczmarek;Katarzyna Koziak;Jean Sévigny;Jonathan B. Siegel.
Journal of Biological Chemistry (1996)
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
Keiichi Enjyoji;Jean Sévigny;Yuan Lin;Paul S. Frenette.
Nature Medicine (1999)
Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants
K. Sato;J. Balla;L. Otterbein;R. N. Smith.
Journal of Immunology (2001)
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium Role of Ectonucleotidases and Adenosine A2B Receptors
Holger K. Eltzschig;Juan C. Ibla;Glenn T. Furuta;Martin O. Leonard.
Journal of Experimental Medicine (2003)
Delayed xenograft rejection
Fritz H. Bach;Hans Winkler;Christiane Ferran;Wayne W. Hancock.
Immunology Today (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Laval
Harvard Medical School
University of Alabama at Birmingham
Columbia University
University of Pennsylvania
Beth Israel Deaconess Medical Center
Goethe University Frankfurt
Harvard Medical School
Beth Israel Deaconess Medical Center
Harvard University
University of Rochester
Florida State University
George Washington University
Wageningen University & Research
University of Tromsø - The Arctic University of Norway
Umeå University
New York Medical College
National University of La Plata
University of Oxford
University of Leeds
University of Wisconsin–Madison
University of Surrey
University of Nottingham
University of Pennsylvania
Deakin University
University of Southern California